Skip to content

INCH-trial: A multicenter randomized controlled trial comparing the efficacy of conventional open surgery and laparoscopic surgery for incisional-hernia repair.

INCH-trial: A multicenter randomized controlled trial comparing the efficacy of conventional open surgery and laparoscopic surgery for incisional-hernia repair. - INCH-trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON41404
Enrollment
250
Registered
2011-08-11
Start date
2012-08-01
Completion date
Unknown
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ventral hernia/ incisional hernia

Interventions

Patients will either undergo laparoscopic or open incisional hernia repair. There two groups will be compared.

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients who: - have an incisional hernia - the need/wish for surgical repair - laparoscopic repair is feasible gave informed consent

Exclusion criteria

Exclusion criteria: Patients who: - Are pregnant - Have an ostomy - Are younger than 18 years old have an open abdomen treatment in the medical history.

Design outcomes

Primary

MeasureTime frame
Primary outcomes are: -Length of hospital stay -Quality of life measures through SF-36 and CCS.

Secondary

MeasureTime frame
Secondary endpoints are: - Time to full recovery within a three months period. -Re-operation rate for recurrence or complications of the incisional hernia repair. The analysis will be continued after the cost-effectiveness study has ended, a longer follow-up is needed to examine the recurrence-rate. -28 days post surgery morbidity and mortality, -Shape of the abdomen: a digital photograph of the abdomen using raster-stereography will be taken pre- and post-operatively to analyse the change in the abdominal shape. -Total mean costs will be related to the following effect measures in the cost-effectiveness analyses: 1) Time to full recovery 2) Quality-adjusted life-years (QALYs) based on the SF-36.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)